Page last updated: 2024-08-21

thiazoles and Small Cell Lung Carcinoma

thiazoles has been researched along with Small Cell Lung Carcinoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Igishi, T; Kodani, M; Matsumoto, S; Matsunami, K; Morita, M; Nakazaki, H; Shigeoka, Y; Shimizu, E; Sumikawa, T; Suyama, H; Takeda, K; Ueda, Y	1
Hodgson, L; Kelley, MJ; Kratzke, RA; Miller, AA; Otterson, GA; Pang, H; Ramnath, N; Vokes, EE	1
Adelman, DC; Crawford, J; Ettinger, DS; Hoch, U; Krug, LM; Michelson, GC; Reiman, T; Shapiro, GI; Spigel, D; Temel, JS; Young, DY	1
Feng, YM; Guo, S; Li, N; Liu, LL; Min, J; Su, HC; Zhang, HL; Zhang, JP	1

Trials

2 trial(s) available for thiazoles and Small Cell Lung Carcinoma

Article	Year
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dasatinib; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thiazoles; Treatment Outcome; Young Adult	2010
Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:2 Topics: Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Naphthyridines; Neoplasm Staging; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thiazoles; Treatment Outcome	2011

Article

Year

A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dasatinib; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thiazoles; Treatment Outcome; Young Adult

2010

Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:2

Topics: Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Naphthyridines; Neoplasm Staging; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thiazoles; Treatment Outcome

2011

Other Studies

2 other study(ies) available for thiazoles and Small Cell Lung Carcinoma

Article	Year
Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells. Oncology reports, 2010, Volume: 23, Issue:1 Topics: Anthracyclines; Benzamides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Imatinib Mesylate; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles	2010
Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer. Molecular biology reports, 2012, Volume: 39, Issue:3 Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Colony-Forming Units Assay; Drug Combinations; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Integrin beta3; Laminin; Proteoglycans; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles	2012

Article

Year

Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.

Oncology reports, 2010, Volume: 23, Issue:1

Topics: Anthracyclines; Benzamides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Imatinib Mesylate; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles

2010

Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer.

Molecular biology reports, 2012, Volume: 39, Issue:3

Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Colony-Forming Units Assay; Drug Combinations; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Integrin beta3; Laminin; Proteoglycans; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles

2012